Bio-Techne Stock

Bio-Techne Dividend

The Dividend of Bio-Techne (TECH) as of Jul 25, 2026 is 0.32 USD. In the previous year, Dividend was 0.32 USD — a change of 0.00% (lower).

Dividend

0.32USD

YoY

0.00%

Dividend yield

0.45 %

Last updated:

How much dividend does Bio-Techne 2026 pay?

According to the latest status from July 2026, Bio-Techne paid a total of 0.32 USD per share in dividends within the last 12 months. With the current Bio-Techne price of 71.63 USD, this corresponds to a dividend yield of 0.45 %. A dividend is paid times per year.

Bio-Techne currently offers a dividend yield of about 0.45%. The payout ratio is around 68% of earnings. The dividend has grown at 1.5% per year over the past 17 years.

Historical Bio-Techne Dividends

A dividend is paid times per year. Last year, the payout months were March, June, September and December.

PaydateDividend
6/18/20260.08USD
3/13/20260.08USD
12/17/20250.08USD
9/18/20250.08USD
6/19/20250.08USD
3/14/20250.08USD
12/8/20240.08USD
9/19/20240.08USD
6/10/20240.08USD
3/9/20240.08USD
12/9/20230.08USD
12/8/20230.08USD
9/17/20230.08USD
6/12/20230.08USD
3/10/20230.08USD
12/10/20220.32USD
9/12/20220.32USD
6/13/20220.32USD
3/25/20220.00USD
3/10/20220.32USD

Bio-Techne dividend history and estimates

In 2025, Bio-Techne paid a dividend amounting to 0.32 USD. Dividend means that Bio-Techne distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2020
1.28 USD
0.00 USD
Jan 1, 2021
1.60 USD
0.00 USD
Jan 1, 2022
1.28 USD
0.00 USD
Jan 1, 2023
0.40 USD
0.00 USD
Jan 1, 2024
0.32 USD
0.00 USD
Jan 1, 2025
0.32 USD
0.00 USD
Jan 1, 2026
0.32 USD
0.00 USD
Jan 1, 2027 (e)
0.00 USD
0.32 USD

Is the Bio-Techne Dividend Safe?

Bio-Techne has been increasing the dividend for 0 years.

Over the past 10 years, Bio-Techne has lowered it by an annual -12.94%.

Over a five-year period, the distribution dropped by -24.21%.

Analysts expect a Dividend Increase of 0.00% for the current fiscal year.

Bio-Techne dividend payout ratio

In 2025, Bio-Techne had a payout ratio of 68.45%. The payout ratio indicates the percentage of the company's profits that Bio-Techne distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
22.47 %
Jan 1, 2021
47.14 %
Jan 1, 2022
19.22 %
Jan 1, 2023
22.44 %
Jan 1, 2024
30.58 %
Jan 1, 2025
68.45 %
Jan 1, 2026 (e)
16.67 %
Jan 1, 2027 (e)
15.65 %

Dividend Details

Understanding Bio-Techne's Dividend Distributions

Bio-Techne’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Bio-Techne's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Bio-Techne's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Bio-Techne’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Bio-Techne Stock analysis

What does Bio-Techne do? Bio-Techne Corp is a global company specializing in the research and development of innovative products and solutions in the field of biosciences. The company was founded in 1976 in Minneapolis and was formerly known as Techne Corporation. Since then, it has grown into an internationally renowned company through its numerous acquisitions and mergers. The company is headquartered in Minneapolis, Minnesota, USA. The business philosophy of Bio-Techne Corp is to help bioscientific researchers and clinicians around the world perform their work more effectively, efficiently, and quickly. The company works closely with its customers to provide them with suitable products and services, thereby developing innovative solutions to the challenges in bioscience. Bio-Techne Corp has various business segments, including protein platforms, diagnostics, genetic analysis, clinical controls, cell culture products, and research reagents. Each business segment offers a variety of products and services to support researchers and clinicians in their work. A key business segment of Bio-Techne Corp is the protein platform, which offers a comprehensive range of proteins, antibodies, and corresponding detection reagents. The company is known for its high-quality proteins and antibodies, which contribute to improving the research of diseases such as cancer, diabetes, and neurological and immunological disorders. Another important business segment of Bio-Techne Corp is diagnostics. Here, the company offers a wide range of clinical diagnostic products, such as tests for analyzing urea, creatinine, and bone density. The company's products help clinicians make precise diagnoses and treat patients more effectively. The genetic analysis segment offers DNA sequencing, gene expression, and genome-wide analysis products and services. These tools enable researchers to better understand the functioning of the human body by exploring the underlying genetic changes. The clinical controls segment offers product and service offerings that improve the reliability and accuracy of diagnostic systems. The company works closely with medical facilities to provide diagnostic solutions that deliver fast and accurate results. The cell culture products segment offers a complete range of solutions for cell cultivation and growth. The offering ranges from basic nutrient media and additives to culture vessels and accessories. The company's products enable researchers to culture cells in a controlled environment and under precise conditions. The last segment of Bio-Techne Corp includes research reagents. Here, the company offers a wide range of reagents used for protein, antibody, and cell function analysis and research. The products meet the needs of researchers in modern bioscience. In summary, Bio-Techne Corp is a company specialized in developing innovative solutions in bioscience, advancing science and medicine. With its products and services offered in various sectors, the company successfully helps researchers and clinicians perform their work faster, more effectively, and cost-efficiently. Bio-Techne is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-Techne stock

Over the past 12 months, Bio-Techne paid a dividend of 0.32 USD . This corresponds to a dividend yield of about 0.45 %. For the coming 12 months, Bio-Techne is expected to pay a dividend of 0.32 USD.

Dividend calendar 2026
Access this data via the Eulerpool API

All Key Metrics — Bio-Techne